$SCPX
Scorpius Holdings, Inc. Stock $scpx

$scpx Overview Financials Valuation SEC Filings Company Website

2015 Q2 Form 10-Q Financial Statement

#000155335015000468 Filed on May 14, 2015

Income Statement

Concept	2015 Q2	2015 Q1	2014 Q1
Revenue	$0.00	$9.126K
YoY Change	-100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$890.0K	$1.310M	$1.010M
YoY Change	-11.88%	29.7%	274.07%
% of Gross Profit
Research & Development	$587.2K	$503.6K	$533.6K
YoY Change	-30.86%	-5.64%	21.2%
% of Gross Profit
Depreciation & Amortization	$28.33K	$25.61K	$2.170K
YoY Change	49.88%	1080.28%	166.58%
% of Gross Profit
Operating Expenses	$4.854M	$3.982M	$2.395M
YoY Change	63.03%	66.28%	210.83%
Operating Profit	-$4.854M	-$3.982M	-$2.395M
YoY Change	63.03%	66.28%	210.83%
Interest Expense	$73.08K	$50.39K
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$48.51K	-$44.69K	-$28.08K
YoY Change	-354.29%	59.12%	56.2%
Pretax Income	-$4.900M	-$4.030M	-$2.420M
YoY Change	65.54%	66.53%	206.33%
Income Tax
% Of Pretax Income
Net Earnings	-$4.713M	-$3.909M	-$2.331M
YoY Change	65.56%	67.73%	-23.93%
Net Earnings / Revenue		-42835.83%
Basic Earnings Per Share
Diluted Earnings Per Share	-$39.25	-$39.10	-$25.88
COMMON SHARES
Basic Shares Outstanding	8.404M shares	8.394M shares	6.452M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2015 Q2	2015 Q1	2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$19.40M	$21.10M	$19.40M
YoY Change	15.48%	8.76%	295.92%
Cash & Equivalents	$11.50M	$10.27M	$2.690M
Short-Term Investments	$7.900M	$10.80M	$16.70M
Other Short-Term Assets	$800.0K	$1.100M	$900.0K
YoY Change	14.29%	22.22%	350.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$20.20M	$22.15M	$20.33M
YoY Change	15.08%	8.94%	298.68%
LONG-TERM ASSETS
Property, Plant & Equipment	$500.0K	$428.2K	$56.74K
YoY Change	3.97%	654.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$200.0K	$251.5K	$10.57K
YoY Change	850.12%	2279.3%	-89.43%
Total Long-Term Assets	$800.0K	$679.7K	$67.31K
YoY Change	59.37%	909.87%	-32.69%
TOTAL ASSETS
Total Short-Term Assets	$20.20M	$22.15M	$20.33M
Total Long-Term Assets	$800.0K	$679.7K	$67.31K
Total Assets	$21.00M	$22.83M	$20.40M
YoY Change	16.31%	11.92%	292.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$800.0K	$819.9K	$378.4K
YoY Change	11.09%	116.69%	-65.6%
Accrued Expenses	$1.200M	$724.5K	$378.5K
YoY Change	274.88%	91.43%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.000M	$700.0K
YoY Change
Total Short-Term Liabilities	$3.000M	$2.248M	$756.9K
YoY Change	188.39%	196.98%	-45.94%
LONG-TERM LIABILITIES
Long-Term Debt	$4.000M	$2.000M	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$12.23K
YoY Change
Total Long-Term Liabilities	$12.23K	$2.000M	$0.00
YoY Change			-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.000M	$2.248M	$756.9K
Total Long-Term Liabilities	$12.23K	$2.000M	$0.00
Total Liabilities	$6.000M	$4.279M	$756.9K
YoY Change	476.78%	465.37%	-68.46%
SHAREHOLDERS EQUITY
Retained Earnings	-$32.76M
YoY Change
Common Stock		$1.361K	$975.00
YoY Change		39.59%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$15.00M	$19.40M	$20.01M
YoY Change
Total Liabilities & Shareholders Equity	$21.00M	$22.83M	$20.40M
YoY Change	16.31%	11.92%	292.31%

Cashflow Statement

Concept	2015 Q2	2015 Q1	2014 Q1
OPERATING ACTIVITIES
Net Income	-$4.713M	-$3.909M	-$2.331M
YoY Change	65.56%	67.73%	-23.93%
Depreciation, Depletion And Amortization	$28.33K	$25.61K	$2.170K
YoY Change	49.88%	1080.28%	166.58%
Cash From Operating Activities	-$3.750M	-$4.462M	-$2.391M
YoY Change	77.73%	86.63%	374.33%
INVESTING ACTIVITIES
Capital Expenditures	$90.00K	$8.280K	$5.155K
YoY Change	-79.55%	60.62%
Acquisitions
YoY Change
Other Investing Activities	$2.840M	-$110.0K	$480.0K
YoY Change	-51.45%	-122.92%
Cash From Investing Activities	$2.730M	-$114.2K	$477.5K
YoY Change	-49.44%	-123.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$11.10M	$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.210M	$11.13M	$36.73K
YoY Change		30204.58%	-99.32%
NET CHANGE
Cash From Operating Activities	-3.750M	-$4.462M	-$2.391M
Cash From Investing Activities	2.730M	-$114.2K	$477.5K
Cash From Financing Activities	2.210M	$11.13M	$36.73K
Net Change In Cash	1.190M	$6.553M	-$1.877M
YoY Change	-63.83%	-449.19%	-138.42%
FREE CASH FLOW
Cash From Operating Activities	-$3.750M	-$4.462M	-$2.391M
Capital Expenditures	$90.00K	$8.280K	$5.155K
Free Cash Flow	-$3.840M	-$4.471M	-$2.396M
YoY Change	50.59%	86.58%	375.35%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q4	us-gaap	Minority Interest MinorityInterest	-729171	USD
CY2015Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	101136	USD
CY2015Q1	us-gaap	Assets Assets	22831276	USD
CY2015Q1	us-gaap	Notes Payable Current NotesPayableCurrent	703341	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10270810	USD
CY2015Q1	us-gaap	Common Stock Value CommonStockValue	1361	USD
CY2015Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	47463159	USD
CY2015Q1	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	28044645	USD
CY2014Q4	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	24135447	USD
CY2015Q1	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	10781058	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	11760358	USD
CY2015Q1	us-gaap	Minority Interest MinorityInterest	-846840	USD
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	982	USD
CY2015Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-20865	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax		USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	15276513	USD
CY2015Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	428202	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	445534	USD
CY2014Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	101129	USD
CY2015Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	69798	USD
CY2014Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	19798	USD
CY2015Q1	us-gaap	Due From Related Parties Noncurrent DueFromRelatedPartiesNoncurrent	58017	USD
CY2014Q4	us-gaap	Due From Related Parties Noncurrent DueFromRelatedPartiesNoncurrent	48642	USD
CY2015Q1	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	22589	USD
CY2014Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	24554	USD
CY2015Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	251540	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	194123	USD
CY2014Q4	us-gaap	Assets Assets	15916170	USD
CY2015Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	819934	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1367426	USD
CY2015Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	724510	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	805968	USD
CY2014Q4	us-gaap	Notes Payable Current NotesPayableCurrent	397465	USD
CY2015Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2247785	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2570859	USD
CY2015Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	2031321	USD
CY2014Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	2314124	USD
CY2015Q1	us-gaap	Liabilities Liabilities	4279106	USD
CY2014Q4	us-gaap	Liabilities Liabilities	4884983	USD
CY2015Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0002
CY2015Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2015Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8394456	shares
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3714304	USD
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6492622	shares
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	35894823	USD
CY2015Q1	us-gaap	Stockholders Equity StockholdersEquity	19399010	USD
CY2015Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	18552170	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	11031187	USD
CY2015Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22831276	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15916170	USD
CY2014Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	10698982	USD
CY2015Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1099666	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	863227	USD
CY2015Q1	us-gaap	Assets Current AssetsCurrent	22151534	USD
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0002
CY2015Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8394456	shares
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6492622	shares
CY2015Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	503551	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3982180	USD
CY2014Q1	us-gaap	Profit Loss ProfitLoss	-2422966	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2394882	USD
CY2015Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	9126	USD
CY2014Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	10975	USD
CY2015Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3420	USD
CY2014Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-39059	USD
CY2015Q1	us-gaap	Interest Expense InterestExpense	50393	USD
CY2014Q1	us-gaap	Interest Expense InterestExpense		USD
CY2015Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-44687	USD
CY2015Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-117669	USD
CY2014Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-92369	USD
CY2014Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-28084	USD
CY2015Q1	us-gaap	Profit Loss ProfitLoss	-4026867	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	-3909198	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	-2330597	USD
CY2015Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.57
CY2014Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.36
CY2015Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	6814863	shares
CY2014Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	6412504	shares
CY2015Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-20865	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax		USD
CY2015Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4047732	USD
CY2014Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	533628	USD
CY2015Q1	htbx	Clinical And Regulatory Expense ClinicalAndRegulatoryExpense	2169473	USD
CY2014Q1	htbx	Clinical And Regulatory Expense ClinicalAndRegulatoryExpense	846384	USD
CY2015Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1309156	USD
CY2014Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1014870	USD
CY2015Q1	us-gaap	Operating Expenses OperatingExpenses	3982180	USD
CY2014Q1	us-gaap	Operating Expenses OperatingExpenses	2394882	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2422966	USD
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-117669	USD
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-92369	USD
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3930063	USD
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2330597	USD
CY2015Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	11400870	USD
CY2015Q1	htbx	Cashless Exercise Of Stock Option CashlessExerciseOfStockOption		USD
CY2015Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		USD
CY2015Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	438751	USD
CY2015Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	270906	USD
CY2015Q1	us-gaap	Depreciation Depreciation	25612	USD
CY2014Q1	us-gaap	Depreciation Depreciation	2170	USD
CY2015Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	25038	USD
CY2014Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		USD
CY2015Q1	htbx	Amortization On Bond Premium AmortizationOnBondPremium	23828	USD
CY2014Q1	htbx	Amortization On Bond Premium AmortizationOnBondPremium	64935	USD
CY2015Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		USD
CY2014Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	20600	USD
CY2015Q1	us-gaap	Share Based Compensation ShareBasedCompensation	438751	USD
CY2014Q1	us-gaap	Share Based Compensation ShareBasedCompensation	169112	USD
CY2015Q1	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	9375	USD
CY2014Q1	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	5146	USD
CY2015Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	252380	USD
CY2014Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-203756	USD
CY2015Q1	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-50000	USD
CY2014Q1	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits		USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-555631	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-273518	USD
CY2015Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-81367	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	36727	USD
CY2015Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	3117	USD
CY2014Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents		USD
CY2015Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	6556506	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1876741	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4566992	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2690251	USD
CY2015Q1	us-gaap	Interest Paid InterestPaid	50393	USD
CY2014Q1	us-gaap	Interest Paid InterestPaid		USD
CY2014Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-124579	USD
CY2015Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet		USD
CY2014Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-25364	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4462391	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2391000	USD
CY2015Q1	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	7811198	USD
CY2014Q1	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	482687	USD
CY2015Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	7917102	USD
CY2014Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments		USD
CY2015Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8280	USD
CY2014Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5155	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-114184	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	477532	USD
CY2015Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	11400870	USD
CY2014Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		USD
CY2015Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		USD
CY2014Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	36727	USD
CY2015Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	270906	USD
CY2014Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	11129964	USD
CY2015Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	530268	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	521988	USD
CY2015Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	102066	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	76454	USD
CY2015Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	208462	USD
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	519092	USD
CY2015Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	45000	USD
CY2014Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	40000	USD
CY2015Q1	us-gaap	Accrued Rent Current AccruedRentCurrent	57643	USD
CY2014Q4	us-gaap	Accrued Rent Current AccruedRentCurrent	51155	USD
CY2015Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	60183	USD
CY2014Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent		USD
CY2015Q1	htbx	Accrued Clinical Trial Expense Current AccruedClinicalTrialExpenseCurrent	353222	USD
CY2014Q4	htbx	Accrued Clinical Trial Expense Current AccruedClinicalTrialExpenseCurrent	195721	USD
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1018590	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.04
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	200000	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	6.23
CY2015Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	6522	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.48
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	157762	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	6.36
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1054306	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.10
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.56
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.896	pure
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0168	pure
CY2015Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y1M6D
CY2015Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	3378681	USD
CY2015Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y8M12D
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	558679	shares
CY2015Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P6Y2M12D
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	3.58
CY2015Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P16M18D
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.58
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	558679	shares
CY2015Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y2M12D
CY2015Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1640000	shares
CY2015Q1	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	6.50
CY2015Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	11100000	USD
CY2015Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2015Q1	dei	Amendment Flag AmendmentFlag	false
CY2015Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2015Q1	dei	Document Period End Date DocumentPeriodEndDate	2015-03-31
CY2015Q1	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2015Q1	dei	Entity Registrant Name EntityRegistrantName	HEAT BIOLOGICS, INC.
CY2015Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001476963
CY2015Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	8404456	shares
CY2015Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2015Q1	dei	Document Type DocumentType	10-Q

Files In Submission

Name	View Source	Status
0001553350-15-000468-index-headers.html	Edgar Link	pending
0001553350-15-000468-index.html	Edgar Link	pending
0001553350-15-000468.txt	Edgar Link	pending
0001553350-15-000468-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
htbx-20150331.xml	Edgar Link	completed
htbx-20150331.xsd	Edgar Link	pending
htbx-20150331_cal.xml	Edgar Link	unprocessable
htbx-20150331_def.xml	Edgar Link	unprocessable
htbx-20150331_lab.xml	Edgar Link	unprocessable
htbx-20150331_pre.xml	Edgar Link	unprocessable
htbx_10q.htm	Edgar Link	pending
htbx_ex31z1.htm	Edgar Link	pending
htbx_ex31z2.htm	Edgar Link	pending
htbx_ex32z1.htm	Edgar Link	pending
htbx_ex32z2.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SCPX
Scorpius Holdings, Inc. Stock $scpx

2015 Q2 Form 10-Q Financial Statement

#000155335015000468 Filed on May 14, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCPX Scorpius Holdings, Inc. Stock $scpx

2015 Q2 Form 10-Q Financial Statement

#000155335015000468 Filed on May 14, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCPX
Scorpius Holdings, Inc. Stock $scpx